Zoely®: firt monophasic coc containing 17β-oestradiol
https://doi.org/10.21518/2079-701X-2013-8-18-19
Abstract
The article tells about the introduction and use of monophasic combined oral contraceptive Zoely®; the peculiar features and unique ingredients of the medicine; efficiency of use and evidence of a reduction in severity of side effects.
About the Author
A. L. Tikhomirov
Moscow State University of Medicine and Dentistry named after A.I. Evdokimov
Russian Federation
Russian Federation
References
1. Прилепская В. Н. Инновации в контрацепции. Зоэли® – новый комбинированный оральный контрацептив. ФГБУ «Научный Центр акушерства, гинекологии и перинатологии им. акад. В. И. Кулакова» Минздравсоцразвития России. 2012.
2. Basdevant A., Pelissier C., Conard J., Degrelle H., Guyene T. T., Thomas J. L. Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal women//Contraception. 1991. № 44. Р. 599–605.
3. Lello S. Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy//Drugs. 2010. № 70. Р. 541–559.
4. Odlind V., Milsom I., Persson I. et al. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?//Acta Obstet. Gynecol. Scand. 2002. № 81. Р. 482–490.
5. Alsina J. C. After 50 years of ethinylestradiol, another oestrogen in combined oral contraceptives//Eur. J. Contracept. Reprod. Health Care. 2010. Feb. № 15 (1). Р. 1–3.
6. Basdevant A., Pelissier C., Conard J., Degrelle H., Guyene T. T., Thomas J. L. Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal women//Contraception. 1991. № 44. Р. 599–605.
7. Ruan X., Seeger H., Mueck A. O. The pharmacology of nomegestrol acetate//Maturitas. 2012. № 7. Р. 345–353.
8. Simoncini T., Caruso A., Garibaldi S. et al. Activation of nitric oxide synthesis in human endothelial cells using nomegestrol acetate// Obstet. Gynecol. 2006. Oct. № 108 (4). Р. 969–978.
9. van Hylckama Vlieg A., Helmerhorst F. M., Vandenbroucke J. P. et al. The venous thrombotic risc of oral contraceptives, effects of estrogen dose and progesterone types: results of the MEGA case-control study//BMJ. 2009. № 339. Р. 2921.
10. Dorangeon P., Thomas J. L., Choisy H., Lumbroso M., Hazard M. C. Effects of nomegestrol acetate on carbohydrate metabolism//Diabete Metab. 1993. № 19. Р. 441–445.
11. Савельева И. С. Молочные железы и гормональная контрацепция//Гинекология. 2000. № 1. С. 32–51.
12. Seeger H., Mueck A. O. Are the progestins responsible for breast cancer risk during hormone therapy in the postmenopause? Experimental vs. clinical data//J. Steroid. Biochem. Mol. Biol. 2008. № 109. Р. 11–15.
13. Ruan X., Neubauer H., Yang Y. et al. Progestogens and membrane-initiated effects on the proliferation of human breast cancer cells// Climacteric. 2012.
14. Ruan X., Schneck H., Schultz S. Nomegestrol acetate sequentially or continuously combined to estradiol did not negatively affect membrane-receptor associated progestogenic effects in human breast cancer cells // Gynecological Endocrinology. 2012. Early Online. Р. 1–4.
15. European Medicines Agency. Zoely (nomegestrol/estradiol): European public assessment report [online]. Available from URL: http:// www. ema. europa.eu/docs/en_GB/document_library/EPAR_Public assessment report/human/001213/ WC500115833.pdf [Accessed 2012 Apr 17].
16. Gaussem P., Alhenc-Gelas M., Thomas J.-L. et al. Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol // Trombosis and Haemostasis. 2011.
17. Agren U.M., Anttila M., Rantala M.L. et al. Effects of monophasic combined oral contraceptive containing nomegestrole acetate and 17b-estadiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function // Eur. J. Contracept. Reprod. Health Care. 2011. №16. Р. 458–467.
Review
For citations:
Tikhomirov AL. Zoely®: firt monophasic coc containing 17β-oestradiol. Meditsinskiy sovet = Medical Council. 2013;(8):18-19. (In Russ.) https://doi.org/10.21518/2079-701X-2013-8-18-19
Views:
955
Email this article 